Novavax Stock News

Bull markets favor growth stocks, and that means many biotech players could benefit. Wall Street believes in the potential of these two biotech innovators.

U.S.-based hedge fund Shah Capital on Monday recommended the appointment of two new independent directors to the Novavax board.

Hedge fund Shah Capital on Monday called for an “urgent shake up” at the board of Novavax over claims its management has failed to capitalize on safety concerns surrounding mRNA vaccines to boost

Bluebird Bio's most recently approved gene editing therapy looks highly promising. Novavax has generated decent revenue from its coronavirus vaccine.

Novavax's business still centers heavily around COVID-19. This year, it expects up to $1 billion in revenue.

To extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple restructuring initiatives that are aimed at lowering operating expenses and enhancing profitability.

Marketbeat's many investor tools include analysts' rankings and sentiment trackers. These tools help investors and traders gauge market sentiment, showing trends and changes, updated revisions, and ne

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Teladoc's position in the growing telemedicine industry could help it turn things around. Novavax's only approved product is going nowhere and its pipeline has too little to offer.

Investing in biopharmaceutical stocks comes with more risks than some other types of stocks.

Novavax's coronavirus franchise isn't performing well. The company has no other product close to approval.

There's a simple reason why short-squeeze stocks to buy represent a powerful catalyst: they're intuitive and easier to engage. Buying something and hoping that it appreciates in value represents an or

Novavax and Ocugen were early contenders in the coronavirus vaccine race -- but didn't meet investors' expectations in that market. As a result, shares of both companies have plummeted.

Big GameStop (NYSE: GME ) and AMC Entertainment (NYSE: AMC ) may have lost investor focus, but these meme stocks keep interests high. Of the many indicators aiding to time the market, short interest r

Healthcare stocks, especially biotech companies, are very risky for investors. Their share price can be highly volatile and surge higher or plummet lower based on news regarding a clinical trial, trea